The Technical Analyst
Select Language :
Vaxart Inc [VXRT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Vaxart Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Vaxart Inc is listed at the  Exchange

0.78% $1.300

America/New_York / 28 mar 2024 @ 16:00


FUNDAMENTALS
MarketCap: 226.02 mill
EPS: -0.570
P/E: -2.28
Earnings Date: May 01, 2024
SharesOutstanding: 173.86 mill
Avg Daily Volume: 2.03 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Buy
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -2.28 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.39x
Company: PE -2.28 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.169
(-86.98%) $-1.131
Date: 2024-03-29
Expected Trading Range (DAY)

$ 1.199 - 1.401

( +/- 7.77%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-18 Tucker Sean Buy 90 000 Common Stock
2024-03-18 Tucker Sean Buy 410 000 Stock Option (right to buy)
2023-03-28 Tucker Sean Sell 3 683 Common Stock
2023-12-08 Tucker Sean Sell 34 288 Common Stock
2024-02-02 Tucker Sean Sell 9 220 Common Stock
INSIDER POWER
94.84
Last 96 transactions
Buy: 11 481 431 | Sell: 272 611

Forecast: 16:00 - $1.300

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $1.300
Forecast 2: 16:00 - $1.300
Forecast 3: 16:00 - $1.300
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.300 (0.78% )
Volume 2.78 mill
Avg. Vol. 2.03 mill
% of Avg. Vol 136.67 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Vaxart Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Vaxart Inc

RSI

Intraday RSI14 chart for Vaxart Inc

Last 10 Buy & Sell Signals For VXRT

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:33buy$1.200N/AActive
Profile picture for
            Vaxart Inc

VXRT

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection. It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus. The company is headquartered in South San Francisco, California.

Last 10 Buy Signals

Date Signal @
HATUSDMar 29 - 05:023 532.25
FETUSDMar 29 - 04:58$3.24
SOCKSUSDMar 29 - 04:5335 606
OSHIUSDMar 29 - 04:4981.91
HBTCUSDMar 29 - 04:3834 558
DESOUSDMar 29 - 04:3931.41
ARUSDMar 29 - 04:28$41.19
KCSUSDMar 29 - 04:24$11.87
FTNUSDMar 29 - 04:141.819
ORAIUSDMar 29 - 04:0814.59

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.